Publication:
The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma

Loading...
Thumbnail Image

Date

2017-05-01T00:00:00Z

Authors

TOSUNER, ZEYNEP
BOZKURT, SÜHEYLA
KILIÇ, TÜRKER
Yilmaz, Baran

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Metrics

Search on Google Scholar

Abstract

Objective: Chordoma is a rare malignant bone tumor with a poor outcome. Although radiotherapy and gamma knife surgery have been used for treatment, providing a cure for the tumor is not easy, because of the frequent recurrences. Molecular targeted therapy against tyrosine kinases has been effective in the treatment of malignancies such as breast and lung cancers and brain tumors. We aimed to analyse the histopathological features of chordomas and the immunoexpression profiles of the three receptor tyrosine kinases of EGFR, c-Met and c-Erb-B2 in chordomas. We have correlated these results with recurrence and overall survival status of the patients.

Description

Keywords

Citation

TOSUNER Z., BOZKURT S., KILIÇ T., Yilmaz B., -The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma-, TURKISH JOURNAL OF PATHOLOGY, cilt.33, ss.112-120, 2017
Page Views

0

File Downloads

4

Sustainable Development Goals